Ilosone Sulfa

   
Google
 
Web NewDrugInformation.com

Ilosone Sulfa


Drug - Ilosone Sulfa
The trade name of the product as shown on the labeling.

Dosage - SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin Estolate; Sulfisoxazole Acetyl
Multiple ingredients are in alphabetical order.

Strength - EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
The potency of the active ingredient(s), Erythromycin Estolate; Sulfisoxazole Acetyl. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Ilosone Sulfa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050599
The FDA assigned number to Ilosone Sulfa. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ilosone Sulfa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 29, 1989
The date Ilosone Sulfa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ilosone Sulfa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Ilosone Sulfa is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Ilosone Sulfa.

Ilosone Sulfa